OC Nnachi, OO Edenya, HC Okoye, CO Akpa, FO Nwani, EI Nwani
{"title":"Plasma Lipid Levels in Relation to Disease Severity in Sickle Cell Anaemia in Abakaliki, Southeast Nigeria","authors":"OC Nnachi, OO Edenya, HC Okoye, CO Akpa, FO Nwani, EI Nwani","doi":"10.30442/ahr.0903-08-210","DOIUrl":null,"url":null,"abstract":"Background: Dyslipidaemia has been implicated in the pathophysiology of sickle cell disease (SCD) complications; hence its role requires further elucidation. Objectives: To investigate the relationship between disease severity and plasma lipid levels of patients with sickle cell anaemia. Methods: A cross-sectional study design was used for the survey. A total of 50 patients with sickle cell anaemia and 50 controls without SCD were recruited for the study. The clinical data and plasma lipid levels of lipids and haemoglobin parameters were analysed. Results: The majority of the participants were aged 18-25 years. Total plasma cholesterol and HDL-C were significantly lower in individuals with SCA compared with the controls (3.3±1.2 vs 4.2±1.2; p<0.001) and (1.3±0.5 vs 1.5±0.4; p = 0.038) respectively. Most patients with SCA had moderate disease severity (24; 48%). There was no statistically significant difference in the plasma levels of total cholesterol and HDL-C across the disease severity groups of SCA (p = 0.694 and 0.262). There was also no significant correlation between total cholesterol, HDL-C, and markers of haemolysis, haemoglobin F, and haemoglobin S levels. Conclusion: SCA is characterised by lower mean plasma TC and HDL than controls. However, no relationship was found between TC, HDL levels and SCD disease severity, markers of haemolysis, HbF and HbS levels. Further studies are required to ascertain the implications of plasma lipid levels in SCD.","PeriodicalId":52960,"journal":{"name":"Annals of Health Research","volume":"158 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30442/ahr.0903-08-210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Dyslipidaemia has been implicated in the pathophysiology of sickle cell disease (SCD) complications; hence its role requires further elucidation. Objectives: To investigate the relationship between disease severity and plasma lipid levels of patients with sickle cell anaemia. Methods: A cross-sectional study design was used for the survey. A total of 50 patients with sickle cell anaemia and 50 controls without SCD were recruited for the study. The clinical data and plasma lipid levels of lipids and haemoglobin parameters were analysed. Results: The majority of the participants were aged 18-25 years. Total plasma cholesterol and HDL-C were significantly lower in individuals with SCA compared with the controls (3.3±1.2 vs 4.2±1.2; p<0.001) and (1.3±0.5 vs 1.5±0.4; p = 0.038) respectively. Most patients with SCA had moderate disease severity (24; 48%). There was no statistically significant difference in the plasma levels of total cholesterol and HDL-C across the disease severity groups of SCA (p = 0.694 and 0.262). There was also no significant correlation between total cholesterol, HDL-C, and markers of haemolysis, haemoglobin F, and haemoglobin S levels. Conclusion: SCA is characterised by lower mean plasma TC and HDL than controls. However, no relationship was found between TC, HDL levels and SCD disease severity, markers of haemolysis, HbF and HbS levels. Further studies are required to ascertain the implications of plasma lipid levels in SCD.
背景:血脂异常与镰状细胞病(SCD)并发症的病理生理有关;因此,它的作用需要进一步阐明。目的:探讨镰状细胞性贫血患者病情严重程度与血脂水平的关系。方法:采用横断面研究设计进行调查。该研究共招募了50名镰状细胞贫血患者和50名无SCD的对照组。分析两组患者的临床资料及血脂水平及血红蛋白参数。结果:大多数参与者年龄在18-25岁之间。与对照组相比,SCA患者血浆总胆固醇和HDL-C显著降低(3.3±1.2 vs 4.2±1.2;P<0.001)和(1.3±0.5 vs 1.5±0.4;P = 0.038)。大多数SCA患者病情严重程度中等(24;48%)。血浆总胆固醇和HDL-C水平在SCA疾病严重程度组间差异无统计学意义(p = 0.694和0.262)。总胆固醇、HDL-C和溶血标志物、血红蛋白F和血红蛋白S水平之间也没有显著相关性。结论:SCA患者的平均血浆TC和HDL低于对照组。然而,TC、HDL水平与SCD疾病严重程度、溶血标志物、HbF和HbS水平之间没有关系。需要进一步的研究来确定血浆脂质水平对SCD的影响。